Cargando…

Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance

BACKGROUND: Artemisinin-based combination therapy, currently considered the therapy of choice for uncomplicated Plasmodium falciparum malaria in endemic countries, may be under threat from newly emerging parasite resistance to the artemisinin family of drugs. Studies in Southeast Asia suggest some p...

Descripción completa

Detalles Bibliográficos
Autores principales: Beshir, Khalid B, Hallett, Rachel L, Eziefula, Alice C, Bailey, Robin, Watson, Julie, Wright, Stephen G, Chiodini, Peter L, Polley, Spencer D, Sutherland, Colin J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992070/
https://www.ncbi.nlm.nih.gov/pubmed/21054863
http://dx.doi.org/10.1186/1475-2875-9-312
_version_ 1782192703159664640
author Beshir, Khalid B
Hallett, Rachel L
Eziefula, Alice C
Bailey, Robin
Watson, Julie
Wright, Stephen G
Chiodini, Peter L
Polley, Spencer D
Sutherland, Colin J
author_facet Beshir, Khalid B
Hallett, Rachel L
Eziefula, Alice C
Bailey, Robin
Watson, Julie
Wright, Stephen G
Chiodini, Peter L
Polley, Spencer D
Sutherland, Colin J
author_sort Beshir, Khalid B
collection PubMed
description BACKGROUND: Artemisinin-based combination therapy, currently considered the therapy of choice for uncomplicated Plasmodium falciparum malaria in endemic countries, may be under threat from newly emerging parasite resistance to the artemisinin family of drugs. Studies in Southeast Asia suggest some patients exhibit an extended parasite clearance time in the three days immediately following treatment with artesunate monotherapy. This phenotype is likely to become a more important trial endpoint in studies of anti-malarial drug efficacy, but currently requires frequent, closely spaced blood sampling in hospitalized study participants, followed by quantitation of parasite density by microscopy. METHODS: A simple duplex quantitative PCR method was developed in which distinct fluorescent signals are generated from the human and parasite DNA components in each blood sample. The human amplification target in this assay is the β tubulin gene, and the parasite target is the unique methionine tRNA gene (pgmet), which exhibits perfect sequence identity in all six Plasmodium species that naturally infect humans. In a small series of malaria cases treated as hospital in-patients, the abundance of pgmet DNA was estimated relative to the human DNA target in daily peripheral blood samples, and parasite clearance times calculated. RESULTS: The qPCR assay was reproducibly able to replicate parasite density estimates derived from microscopy, but provided additional data by quantification of parasite density 24 hours after the last positive blood film. Robust estimates of parasite clearance times were produced for a series of patients with clinical malaria. CONCLUSIONS: Large studies, particularly in Africa where children represent a major proportion of treated cases, will require a simpler blood sample collection regime, and a method capable of high throughput. The duplex qPCR method tested may fulfil these criteria, and should now be evaluated in such field studies.
format Text
id pubmed-2992070
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29920702010-12-20 Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance Beshir, Khalid B Hallett, Rachel L Eziefula, Alice C Bailey, Robin Watson, Julie Wright, Stephen G Chiodini, Peter L Polley, Spencer D Sutherland, Colin J Malar J Research BACKGROUND: Artemisinin-based combination therapy, currently considered the therapy of choice for uncomplicated Plasmodium falciparum malaria in endemic countries, may be under threat from newly emerging parasite resistance to the artemisinin family of drugs. Studies in Southeast Asia suggest some patients exhibit an extended parasite clearance time in the three days immediately following treatment with artesunate monotherapy. This phenotype is likely to become a more important trial endpoint in studies of anti-malarial drug efficacy, but currently requires frequent, closely spaced blood sampling in hospitalized study participants, followed by quantitation of parasite density by microscopy. METHODS: A simple duplex quantitative PCR method was developed in which distinct fluorescent signals are generated from the human and parasite DNA components in each blood sample. The human amplification target in this assay is the β tubulin gene, and the parasite target is the unique methionine tRNA gene (pgmet), which exhibits perfect sequence identity in all six Plasmodium species that naturally infect humans. In a small series of malaria cases treated as hospital in-patients, the abundance of pgmet DNA was estimated relative to the human DNA target in daily peripheral blood samples, and parasite clearance times calculated. RESULTS: The qPCR assay was reproducibly able to replicate parasite density estimates derived from microscopy, but provided additional data by quantification of parasite density 24 hours after the last positive blood film. Robust estimates of parasite clearance times were produced for a series of patients with clinical malaria. CONCLUSIONS: Large studies, particularly in Africa where children represent a major proportion of treated cases, will require a simpler blood sample collection regime, and a method capable of high throughput. The duplex qPCR method tested may fulfil these criteria, and should now be evaluated in such field studies. BioMed Central 2010-11-05 /pmc/articles/PMC2992070/ /pubmed/21054863 http://dx.doi.org/10.1186/1475-2875-9-312 Text en Copyright ©2010 Beshir et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Beshir, Khalid B
Hallett, Rachel L
Eziefula, Alice C
Bailey, Robin
Watson, Julie
Wright, Stephen G
Chiodini, Peter L
Polley, Spencer D
Sutherland, Colin J
Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance
title Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance
title_full Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance
title_fullStr Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance
title_full_unstemmed Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance
title_short Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance
title_sort measuring the efficacy of anti-malarial drugs in vivo: quantitative pcr measurement of parasite clearance
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992070/
https://www.ncbi.nlm.nih.gov/pubmed/21054863
http://dx.doi.org/10.1186/1475-2875-9-312
work_keys_str_mv AT beshirkhalidb measuringtheefficacyofantimalarialdrugsinvivoquantitativepcrmeasurementofparasiteclearance
AT hallettrachell measuringtheefficacyofantimalarialdrugsinvivoquantitativepcrmeasurementofparasiteclearance
AT eziefulaalicec measuringtheefficacyofantimalarialdrugsinvivoquantitativepcrmeasurementofparasiteclearance
AT baileyrobin measuringtheefficacyofantimalarialdrugsinvivoquantitativepcrmeasurementofparasiteclearance
AT watsonjulie measuringtheefficacyofantimalarialdrugsinvivoquantitativepcrmeasurementofparasiteclearance
AT wrightstepheng measuringtheefficacyofantimalarialdrugsinvivoquantitativepcrmeasurementofparasiteclearance
AT chiodinipeterl measuringtheefficacyofantimalarialdrugsinvivoquantitativepcrmeasurementofparasiteclearance
AT polleyspencerd measuringtheefficacyofantimalarialdrugsinvivoquantitativepcrmeasurementofparasiteclearance
AT sutherlandcolinj measuringtheefficacyofantimalarialdrugsinvivoquantitativepcrmeasurementofparasiteclearance